[ad_1]
The team responsible for the AstraZeneca vaccine against the Corona virus has reached a new vaccine which is described as the optimal treatment for cancer patients.
The team is preparing to test this vaccine for the first time on humans, in particular on 80 patients with lung cancer.
The new vaccine, according to “The Times” newspaper, is based on the same “virus vector” technology that was used in the dose of the “Oxford-AstraZeneca” vaccine.
The genetic material in the vaccine causes the body to respond to molecules called “Mage” proteins found in cancer cells.
[ad_2]
Source link
